Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

3.

A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.

Behounek BD, McGovern ME, Kassler-Taub KB, Markowitz JS, Bergman M.

Clin Cardiol. 1994 Oct;17(10):558-62.

PMID:
8001304
[PubMed - indexed for MEDLINE]
5.

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).

Lancet. 2002 Apr 20;359(9315):1379-87. Erratum in: Lancet 2002 Nov 2;360(9343):1430.

PMID:
11978335
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.

Raskin P, Ganda OP, Schwartz S, Willard D, Rosenstock J, Lodewick PA, Cressman MD, Phillipson B, Weiner B, McGovern ME, et al.

Am J Med. 1995 Oct;99(4):362-9.

PMID:
7573090
[PubMed - indexed for MEDLINE]
7.

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E.

Ann Intern Med. 1998 Nov 1;129(9):681-9.

PMID:
9841599
[PubMed - indexed for MEDLINE]
8.

Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.

Krempf M, Berthezène F, Wemeau JL, Moinade S, Desriac I, Amelineau E, Passa P.

Diabetes Metab. 1997 Apr;23(2):131-6.

PMID:
9137901
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.

Wolffenbuttel BH, Mahla G, Muller D, Pentrup A, Black DM.

Neth J Med. 1998 Apr;52(4):131-7.

PMID:
9646621
[PubMed - indexed for MEDLINE]
10.

Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.

Saito Y, Shirai K, Sasaki N, Shinomiya M, Yoshida S; Committee of the Chiba Lipid Intervention Program Study.

J Atheroscler Thromb. 2002;9(2):99-108.

PMID:
12236319
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ.

N Engl J Med. 1995 Nov 16;333(20):1301-7.

PMID:
7566020
[PubMed - indexed for MEDLINE]
Free Article
12.

Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.

Morris R, Robinson G, Tilyard M, Gurr E.

N Z Med J. 1996 Aug 23;109(1028):319-22.

PMID:
8816723
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.

Santinga JT, Rosman HS, Rubenfire M, Maciejko JJ, Kobylak L, McGovern ME, Behounek BD.

Am J Med. 1994 Jun;96(6):509-15.

PMID:
8017448
[PubMed - indexed for MEDLINE]
14.

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.

Pfeffer MA, Sacks FM, Moyé LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JL, Sussex BA, Theroux P, Vanden Belt RJ, Braunwald E.

J Am Coll Cardiol. 1999 Jan;33(1):125-30.

PMID:
9935018
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
[PubMed - indexed for MEDLINE]
17.

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).

Byington RP, Furberg CD, Crouse JR 3rd, Espeland MA, Bond MG.

Am J Cardiol. 1995 Sep 28;76(9):54C-59C.

PMID:
7572688
[PubMed - indexed for MEDLINE]
18.

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

[No authors listed]

Lancet. 1994 Nov 19;344(8934):1383-9.

PMID:
7968073
[PubMed - indexed for MEDLINE]
19.

Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators.

Am Heart J. 2003 Apr;145(4):643-51.

PMID:
12679760
[PubMed - indexed for MEDLINE]
20.

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A.

Ann Intern Med. 2001 May 15;134(10):931-40.

PMID:
11352694
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk